Suchbegriffe: ANGIOGENESIS INHIBITORS - ADVERSE EFFECTS ANGIOGENESIS INHIBITORS - THERAPEUTIC USE , . Treffer: 2
Pansy, J; Fritsch, P; Sovinz, P; Lackner, H; Schwinger, W; Urban, C; Benesch, M
Add-on-therapy with bevacizumab in children and adolescents with poor prognosis non-CNS solid tumors.
Anticancer Drugs. 2013; 24(2):198-203
Doi: 10.1097/CAD.0b013e32835b9589
Web of Science
PubMed
FullText
FullText_MUG
D'Angelica, M; Kornprat, P; Gonen, M; Chung, KY; Jarnagin, WR; DeMatteo, RP; Fong, Y; Kemeny, N; Blumgart, LH; Saltz, LB
Lack of evidence for increased operative morbidity after hepatectomy with perioperative use of bevacizumab: a matched case-control study.
Ann Surg Oncol. 2007; 14(2):759-765
Doi: 10.1245/s10434-006-9074-0
Web of Science
PubMed
FullText
FullText_MUG